tradingkey.logo

Heartbeam Inc

BEAT
3.100USD
+0.390+14.39%
Close 12/19, 16:00ETQuotes delayed by 15 min
106.46MMarket Cap
LossP/E TTM

Heartbeam Inc

3.100
+0.390+14.39%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Heartbeam Inc

Currency: USD Updated: 2025-10-27

Key Insights

Its valuation is considered fairly valued, Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at max_target_price.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Heartbeam Inc's Score

Industry at a Glance

Industry Ranking
159 / 204
Overall Ranking
468 / 4682
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
3.875
Target Price
+385.04%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Heartbeam Inc Highlights

StrengthsRisks
HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 0.00.
Fairly Valued
The company’s latest PE is -2.32, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 3.60M shares, increasing 9.65% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 1.12M shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-27

No financial score is currently available for Heartbeam Inc. The Healthcare Equipment & Supplies industry's average is 7.47.

Score

Industry at a Glance

Previous score
0.00
Change
0

Financials

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

Operational Efficiency

Growth Potential

Shareholder Returns

Heartbeam Inc's Company Valuation

Currency: USD Updated: 2025-10-27

The current valuation score of Heartbeam Inc is 7.73, ranking industry_rank/industry_total in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -2.32, which is -56.73% below the recent high of -1.00 and -224.64% above the recent low of -7.53.

Score

Industry at a Glance

Previous score
7.73
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 159/204
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-10-27

The current earnings forecast score of Heartbeam Inc is 7.00, ranking industry_rank/industry_total in the Healthcare Equipment & Supplies industry. The average price target for Heartbeam Inc is 4.50, with a high of 8.00 and a low of 1.00.

Score

Industry at a Glance

Previous score
7.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
3.875
Target Price
+385.04%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

90
Total
4
Median
7
Average
Company name
Ratings
Analysts
Heartbeam Inc
BEAT
4
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
34
Intuitive Surgical Inc
ISRG
34
Thermo Fisher Scientific Inc
TMO
27
1
2
3
...
18

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-27

The current price momentum score of Heartbeam Inc is 6.52, ranking industry_rank/industry_total in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 1.91 and the support level at 1.42, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.55
Change
-0.03

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(0)
Neutral(2)
Buy(5)
Indicators
Value
Direction
MACD(12,26,9)
0.495
Buy
RSI(14)
70.073
Buy
STOCH(KDJ)(9,3,3)
70.708
Neutral
ATR(14)
0.564
High Vlolatility
CCI(14)
81.280
Neutral
Williams %R
26.947
Buy
TRIX(12,20)
4.013
Buy
StochRSI(14)
21.209
Buy
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
2.990
Buy
MA10
2.252
Buy
MA20
1.475
Buy
MA50
1.588
Buy
MA100
1.477
Buy
MA200
1.558
Buy

Institutional Confidence

Currency: USD Updated: 2025-10-27

The current institutional shareholding score of Heartbeam Inc is 3.00, ranking industry_rank/industry_total in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 10.48%, representing a quarter-over-quarter decrease of 68.69%. The largest institutional shareholder is The Vanguard, holding a total of 1.12M shares, representing 3.26% of shares outstanding, with 13.81% increase in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Strome Mezzanine Fund, L.P.
3.15M
--
Schwartzberg (Andrew)
1.90M
--
The Vanguard Group, Inc.
Star Investors
1.12M
+35.89%
Public Ventures LLC
1.07M
+0.37%
Vajdic (Branislav)
911.39K
+0.14%
Elfrink (Willhem P.)
424.81K
--
Smith, Salley & Associates, LLC
367.65K
--
Geode Capital Management, L.L.C.
254.87K
+3.03%
Ferrari (Richard M)
244.79K
--
UBS Financial Services, Inc.
199.27K
-1.86%
1
2

Risk Assessment

Currency: USD Updated: 2025-10-27

No risk assessment score is currently available for Heartbeam Inc. The Healthcare Equipment & Supplies industry's average is 4.64. The company's beta value is -0.64. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
0.00
Change
0
Beta vs S&P 500 index
-1.26
VaR
--
240-Day Maximum Drawdown
+76.51%
240-Day Volatility
+153.73%

Return

Best Daily Return
60 days
+92.43%
120 days
+92.43%
5 years
--
Worst Daily Return
60 days
-53.51%
120 days
-53.51%
5 years
--
Sharpe Ratio
60 days
+2.17
120 days
+1.84
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+76.51%
3 years
+85.06%
5 years
--
Return-to-Drawdown Ratio
240 days
+0.48
3 years
-0.08
5 years
--
Skewness
240 days
+3.93
3 years
+3.25
5 years
--

Volatility

Realised Volatility
240 days
+153.73%
5 years
--
Standardised True Range
240 days
+5.08%
5 years
--
Downside Risk-Adjusted Return
120 days
+305.24%
240 days
+305.24%
Maximum Daily Upside Volatility
60 days
+326.88%
Maximum Daily Downside Volatility
60 days
+193.27%

Liquidity

Average Turnover Rate
60 days
+0.35%
120 days
+0.28%
5 years
--
Turnover Deviation
20 days
-19.82%
60 days
-24.23%
120 days
-38.70%

Peer Comparison

Healthcare Equipment & Supplies
Heartbeam Inc
Heartbeam Inc
BEAT
4.16 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
Artivion Inc
AORT
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
Tactile Systems Technology Inc
TCMD
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Heartbeam Inc?

The TradingKey Stock Score provides a comprehensive assessment of Heartbeam Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Heartbeam Inc’s performance and outlook.

How do we generate the financial health score of Heartbeam Inc?

To generate the financial health score of Heartbeam Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Heartbeam Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Heartbeam Inc.

How do we generate the company valuation score of Heartbeam Inc?

To generate the company valuation score of Heartbeam Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Heartbeam Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Heartbeam Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Heartbeam Inc.

How do we generate the earnings forecast score of Heartbeam Inc?

To calculate the earnings forecast score of Heartbeam Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Heartbeam Inc’s future.

How do we generate the price momentum score of Heartbeam Inc?

When generating the price momentum score for Heartbeam Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Heartbeam Inc’s prices. A higher score indicates a more stable short-term price trend for Heartbeam Inc.

How do we generate the institutional confidence score of Heartbeam Inc?

To generate the institutional confidence score of Heartbeam Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Heartbeam Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Heartbeam Inc.

How do we generate the risk management score of Heartbeam Inc?

To assess the risk management score of Heartbeam Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Heartbeam Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Heartbeam Inc.
KeyAI